Jaineya, Myra .
HRN: 13-33-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/11/2022
09/18/2022
IV
1.2g
Q6hours
Sepsis Sec To AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes